Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 348

    1.

    Role of insulin resistance in predicting progression to type 1 diabetes.

    Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2007 Sep;30(9):2314-20. Epub 2007 May 29.PMID: 17536068 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin resistance is a risk factor for progression to type 1 diabetes.

    Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC.

    Diabetologia. 2004 Oct;47(10):1661-7. Epub 2004 Oct 6. Erratum in: Diabetologia. 2004 Dec;47(12):2247. PMID: 15480539 [PubMed - indexed for MEDLINE]Related articles

    3.

    Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT).

    Bingley PJ, Mahon JL, Gale EA; European Nicotinamide Diabetes Intervention Trial Group.

    Diabetes Care. 2008 Jan;31(1):146-50. Epub 2007 Oct 24.PMID: 17959864 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing to type 1 diabetes: a study of identical twins.

    Hawa MI, Bonfanti R, Valeri C, Delli Castelli M, Beyan H, Leslie RD.

    Diabetes Care. 2005 Jun;28(6):1415-8.PMID: 15920061 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study.

    Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu S.

    Diabetes Care. 2007 Jul;30(7):1747-52. Epub 2007 Apr 27.PMID: 17468352 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

    Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

    Pediatr Diabetes. 2004 Jun;5(2):72-9.PMID: 15189492 [PubMed - indexed for MEDLINE]Related articles

    7.

    The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects.

    Sugiura M, Nakamura M, Ikoma Y, Yano M, Ogawa K, Matsumoto H, Kato M, Ohshima M, Nagao A.

    J Epidemiol. 2006 Mar;16(2):71-8.PMID: 16537987 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

    Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M.

    Diabetes Care. 2002 Jul;25(7):1135-41.PMID: 12087010 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study.

    Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M.

    Diabetes Care. 2007 Feb;30(2):318-24.PMID: 17259501 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Models for predicting type 1 diabetes in siblings of affected children.

    Mrena S, Virtanen SM, Laippala P, Kulmala P, Hannila ML, Akerblom HK, Knip M.

    Diabetes Care. 2006 Mar;29(3):662-7.PMID: 16505523 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trial.

    Rodríguez-Villar C, Conget I, Casamitjana R, Ercilla G, Gomis R.

    Diabet Med. 1999 Feb;16(2):160-3.PMID: 10229311 [PubMed - indexed for MEDLINE]Related articles

    12.

    Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.

    Viswanathan V, Clementina M, Nair BM, Satyavani K.

    J Assoc Physicians India. 2007 Dec;55:833-7.PMID: 18405128 [PubMed - indexed for MEDLINE]Related articles

    14.

    Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband.

    Tripathy D, Lindholm E, Isomaa B, Saloranta C, Tuomi T, Groop L.

    Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1297-303. Epub 2003 Sep 3.PMID: 12954593 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus.

    Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L.

    BMC Cardiovasc Disord. 2006 May 2;6:19.PMID: 16670002 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.

    Diabetes Care. 2006 Jul;29(7):1613-8.PMID: 16801587 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.

    Esteghamati A, Khalilzadeh O, Abbasi M, Nakhjavani M, Novin L, Esteghamati AR.

    Clin Exp Hypertens. 2008 Jul;30(5):297-307.PMID: 18633753 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin resistance in men with treated hypertension at increased risk for cardiovascular disease: results of a 3-year study.

    Mohteshamzadeh M, Wilkinson R, Thomas SH.

    Am J Hypertens. 2005 Apr;18(4 Pt 1):452-6.PMID: 15831352 [PubMed - indexed for MEDLINE]Related articles

    19.

    First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes.

    Chase HP, Cuthbertson DD, Dolan LM, Kaufman F, Krischer JP, Schatz DA, White NH, Wilson DM, Wolfsdorf J.

    J Pediatr. 2001 Feb;138(2):244-9.PMID: 11174623 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.

    Limburg PJ, Stolzenberg-Solomon RZ, Vierkant RA, Roberts K, Sellers TA, Taylor PR, Virtamo J, Cerhan JR, Albanes D.

    Clin Gastroenterol Hepatol. 2006 Dec;4(12):1514-21.PMID: 17162243 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data